Furthermore, patients whose tumours exhibited EIF4EBP1 expression alteration had significantly poorer disease-free survival (Figure 2A; P = 0.042) and overall survival (Figure 2B; P < 0.001). Here, EIF4EBP1 is linked to neoplasm.